Part D/Prescription Drugs – Page 59 – medicarereport.org

Friday, September 11, 2026

Latest:

CMS Health Care - General Medicare - General Medicare Advantage Part D/Prescription Drugs

Arlene Sharp October 7, 2022October 7, 2022 medicare, Medicare Advantage, Part C, Part D

CMS Releases 2023 Medicare Advantage and Part D Star Ratings to Help People with Medicare Compare Plans

(News Release by CMS.gov on October 6, 2022) The Centers for Medicare & Medicaid Services (CMS) released the 2023 Star

Aging Health Care - General Mental Health/Behavioral Health Part D/Prescription Drugs

Arlene Sharp October 6, 2022October 6, 2022 Aging, ALS, brain disease, Pharmaceutical

A New Drug For A Relentless Brain Disease

(By Jon Hamilton and Thomas Lu for NPR on October 5, 2022) ALS is a disease that gradually destroys the

Aging Health Care - General Medicare - General Part D/Prescription Drugs

Arlene Sharp October 3, 2022October 3, 2022 drugs, pharmaceuticals

The 10 drugs most likely to be the 1st negotiated by Medicare

(By Rylee Wilson for Becker’s Hospital Review on September 30, 2022) The first drugs negotiated by Medicare are likely to

CMS Health Care Finance Medicare Advantage Part D/Prescription Drugs

Eileen Cook September 30, 2022September 30, 2022 CMS, Medicare Advantage, Medicare Part D, Medicare Premiums

Medicare Advantage premiums to decrease

(By Rylee Wilson for Becker’s Hospital Review ) Medicare Advantage premiums will decrease for 2023, CMS said Sept. 29, continuing

Alzheimer’s/Dementia FDA Part D/Prescription Drugs

Eileen Cook September 30, 2022September 30, 2022 Alzheimer’s Disease, FDA, New Drug, Treatment Option

FDA approves ALS drug from Amylyx, giving patients a much-needed treatment option

(By Damian Garde for ST A T) The Food and Drug Administration approved a new medicine for ALS from Amylyx

FDA Part D/Prescription Drugs

Eileen Cook September 30, 2022September 30, 2022 FDA, FDA’s accelerated approval, Pharmaceutical

Pharma-Funded FDA Gets Drugs Out Faster, But Some Work Only ‘Marginally’ and Most Are Pricey

(By Arthur Allen for Kaiser Health News) Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful

Alzheimer’s/Dementia Part D/Prescription Drugs

Eileen Cook September 29, 2022September 29, 2022 Alzheimer’s Disease

An Alzheimer’s therapy scores winning results, but what could it mean for patients?

(By Andrew Joseph for ST A T) The news Tuesday night that a clinical trial of an experimental Alzheimer’s therapy

CMS Medicare - General Part D/Prescription Drugs

Eileen Cook September 27, 2022September 27, 2022 IRMAA, medicare, Medicare Part D, Medicare Premiums

2023 Medicare Parts A & B Premiums and Deductibles 2023 Medicare Part D Income-Related Monthly Adjustment Amounts

(Source - www.cms.gov) On September 27, 2022, the Centers for Medicare & Medicaid Services (CMS) released the 2023 premiums, deductibles,

Part D/Prescription Drugs Veterans Benefits

Eileen Cook September 27, 2022September 27, 2022 Express Scripts, Tricare

Thousands of independent pharmacies to be dropped from Tricare network

(By Rylee Wilson for Becker’s Hospital Review ) Nearly 15,000 independent and community pharmacies will be dropped from Tricare’s network

Medicare - General Part D/Prescription Drugs

Eileen Cook September 26, 2022September 26, 2022 Late Enrollment Penalty, medicare, Medicare Part B, Medicare Part D

Avoid the Late Enrollment Penalty Pitfall

Article provided by John Patrick Buckwell for the AMAC Foundation website Each day approximately 10,000 baby boomers reach Medicare age,